Stock To Watch: ABIOMED, Inc. (NASDAQ:ABMD)


The leading market experts have placed a mean price target of $122.38 on ABIOMED, Inc. (NASDAQ:ABMD) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.25 a share for the upcoming quarter and $1.13 for the current fiscal. Technical View The technical analysis of ABIOMED, Inc. plainly substantiates that the 50-day moving average of ABIOMED, Inc. is $108.27, and stock is hovering 7.98 or +7.37% distant from $108.27. It is noted that the 200-day MA is $94.69, and ABIOMED, Inc. stock is $21.56 or +22.77% off from this point. ABIOMED, Inc. (NASDAQ:ABMD) 52-week high is $119.90 and the 52-week low is $67.81. This explains if the stock moves $-3.65, it will post a 52-week high. In event of $+71.43% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of ABIOMED, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, ABIOMED, Inc. (NASDAQ:ABMD) ratio came in at 136.76. The stock last ended the trading session at $116.25 and registered a market cap of $4.94B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. ABIOMED, Inc. (NASDAQ:ABMD) PEG ratio is at 3.73.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)